Hologic Inc.
Verstreken Jan Files Hologic (HOLX) Form 4 - November 07, 2025
Transactions
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Verstreken Jan | 2025-11-11 | Sell | 178 | $74.60 | $13.3K | Direct |
| Verstreken Jan | 2025-11-10 | Buy | 16.8K | - | $0.00 | Direct |
| Verstreken Jan | 2025-11-07 | Sell | 1.4K | $74.10 | $105.2K | Direct |
Track HOLX insider activity
Get alerts when Hologic Inc. executives trade their shares.
About Hologic Inc.
Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.
Official SEC Documents